These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 36369740)

  • 1. Capillary transit time heterogeneity inhibits cerebral oxygen metabolism in patients with reduced cerebrovascular reserve capacity from steno-occlusive disease.
    Vestergaard MB; Iversen HK; Simonsen SA; Lindberg U; Cramer SP; Andersen UB; Larsson HB
    J Cereb Blood Flow Metab; 2023 Mar; 43(3):460-475. PubMed ID: 36369740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain capillary transit time heterogeneity in healthy volunteers measured by dynamic contrast-enhanced T
    Larsson HBW; Vestergaard MB; Lindberg U; Iversen HK; Cramer SP
    J Magn Reson Imaging; 2017 Jun; 45(6):1809-1820. PubMed ID: 27731907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of capillary transit time heterogeneity (CTH) on brain oxygenation.
    Angleys H; Østergaard L; Jespersen SN
    J Cereb Blood Flow Metab; 2015 May; 35(5):806-17. PubMed ID: 25669911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of pseudoprogression in post-treatment glioblastoma using dynamic susceptibility contrast-derived oxygenation and microvascular transit time heterogeneity measures.
    Park JE; Kim HS; Kim N; Borra R; Mouridsen K; Hansen MB; Kim YH; Hong CK; Kim JH
    Eur Radiol; 2024 May; 34(5):3061-3073. PubMed ID: 37848773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reliable estimation of capillary transit time distributions using DSC-MRI.
    Mouridsen K; Hansen MB; Østergaard L; Jespersen SN
    J Cereb Blood Flow Metab; 2014 Sep; 34(9):1511-21. PubMed ID: 24938401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated PET/MRI scanner with oxygen-15 labeled gases for quantification of cerebral blood flow, cerebral blood volume, cerebral oxygen extraction fraction and cerebral metabolic rate of oxygen.
    Ito H; Kubo H; Takahashi K; Nishijima KI; Ukon N; Nemoto A; Sugawara S; Yamakuni R; Ibaraki M; Ishii S
    Ann Nucl Med; 2021 Apr; 35(4):421-428. PubMed ID: 33502738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuronal activation induced BOLD and CBF responses upon acetazolamide administration in patients with steno-occlusive artery disease.
    Siero JC; Hartkamp NS; Donahue MJ; Harteveld AA; Compter A; Petersen ET; Hendrikse J
    Neuroimage; 2015 Jan; 105():276-85. PubMed ID: 25261002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated global cerebral blood flow, oxygen extraction fraction and unchanged metabolic rate of oxygen in young adults with end-stage renal disease: an MRI study.
    Zheng G; Wen J; Lu H; Lou Y; Pan Z; Liu W; Liu H; Li X; Zhang Z; Chen H; Kong X; Luo S; Jiang X; Liu Y; Zhang Z; Zhang LJ; Lu GM
    Eur Radiol; 2016 Jun; 26(6):1732-41. PubMed ID: 26334507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-Parametric Evaluation of Cerebral Hemodynamics in Neonatal Piglets Using Non-Contrast-Enhanced Magnetic Resonance Imaging Methods.
    Liu D; Jiang D; Tekes A; Kulikowicz E; Martin LJ; Lee JK; Liu P; Qin Q
    J Magn Reson Imaging; 2021 Oct; 54(4):1053-1065. PubMed ID: 33955613
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between cerebral circulatory reserve and oxygen extraction fraction in patients with major cerebral artery occlusive disease: a positron emission tomography study.
    Yata K; Suzuki A; Hatazawa J; Shimosegawa E; Nagata K; Sato M; Moroi J
    Stroke; 2006 Feb; 37(2):534-6. PubMed ID: 16410481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal timing for measuring cerebral blood flow after acetazolamide administration to detect preexisting cerebral hemodynamics and metabolism in patients with bilateral major cerebral artery steno-occlusive diseases:
    Kobayashi M; Igarashi S; Takahashi T; Fujiwara S; Chida K; Terasaki K; Kubo Y; Ogasawara K
    Am J Nucl Med Mol Imaging; 2021; 11(6):507-518. PubMed ID: 35003888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET evaluation of cerebral hemodynamics in occlusive cerebrovascular disease pre- and postsurgery.
    Kuwabara Y; Ichiya Y; Sasaki M; Yoshida T; Fukumura T; Masuda K; Fujii K; Fukui M
    J Nucl Med; 1998 May; 39(5):760-5. PubMed ID: 9591570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local brain haemodynamics and oxygen metabolism in cerebrovascular disease. Positron emission tomography.
    Sette G; Baron JC; Mazoyer B; Levasseur M; Pappata S; Crouzel C
    Brain; 1989 Aug; 112 ( Pt 4)():931-51. PubMed ID: 2789086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
    Nielsen RB; Egefjord L; Angleys H; Mouridsen K; Gejl M; Møller A; Brock B; Brændgaard H; Gottrup H; Rungby J; Eskildsen SF; Østergaard L
    Alzheimers Dement; 2017 Oct; 13(10):1143-1153. PubMed ID: 28343848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral oxygen metabolism in adults with sickle cell disease.
    Václavů L; Petr J; Petersen ET; Mutsaerts HJMM; Majoie CBL; Wood JC; VanBavel E; Nederveen AJ; Biemond BJ
    Am J Hematol; 2020 Apr; 95(4):401-412. PubMed ID: 31919876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebral MR oximetry during acetazolamide augmentation: Beyond cerebrovascular reactivity in hemodynamic failure.
    Leatherday C; Dehkharghani S; Nahab F; Allen JW; Wu J; Hu R; Qiu D
    J Magn Reson Imaging; 2019 Jul; 50(1):175-182. PubMed ID: 30390367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severity-specific alterations in CBF, OEF and CMRO2 in cirrhotic patients with hepatic encephalopathy.
    Zheng G; Lu H; Yu W; Luo S; Liu Y; Liu W; Liu H; Wu L; Zheng L; Kong X; Zhang LJ; Lu GM
    Eur Radiol; 2017 Nov; 27(11):4699-4709. PubMed ID: 28523351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of cerebrovascular reserve in acetazolamide challenge -comparison with acetazolamide challenge H2O-PET and Gas-PET.
    Imaizumi M; Kitagawa K; Oku N; Hashikawa K; Takasawa M; Yoshikawa T; Osaki Y; Matsushita K; Matsumoto M; Hori M; Hatazawa J
    Ann Nucl Med; 2004 Jul; 18(5):369-74. PubMed ID: 15462398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can the detection of misery perfusion in chronic cerebrovascular disease be based on reductions in baseline CBF and vasoreactivity?
    Okazawa H; Tsuchida T; Kobayashi M; Arai Y; Pagani M; Isozaki M; Yonekura Y
    Eur J Nucl Med Mol Imaging; 2007 Jan; 34(1):121-9. PubMed ID: 16896662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variability of cerebral blood volume and oxygen extraction: stages of cerebral haemodynamic impairment revisited.
    Derdeyn CP; Videen TO; Yundt KD; Fritsch SM; Carpenter DA; Grubb RL; Powers WJ
    Brain; 2002 Mar; 125(Pt 3):595-607. PubMed ID: 11872616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.